Aspartate 0 9 0 9 B-clinical_variable
aminotransferase 10 26 10 26 I-clinical_variable
or 27 29 27 29 I-clinical_variable
alanine 30 37 30 37 I-clinical_variable
aminotransferase 38 54 38 54 I-clinical_variable
≥ 55 56 55 56 O
3X 57 59 57 59 B-lower_bound
ULN 60 63 60 63 I-lower_bound
or 64 66 64 66 O
total 67 72 67 72 O
bilirubin 73 82 73 82 B-clinical_variable
≥ 83 84 83 84 O
1.5X 85 89 85 89 B-lower_bound
ULN 90 93 90 93 I-lower_bound

BMI 0 3 94 97 B-bmi
outside 4 11 98 105 O
the 12 15 106 109 O
range 16 21 110 115 O
( 22 23 116 117 O
below 23 28 117 122 O
the 29 32 123 126 O
5th 33 36 127 130 B-upper_bound
percentile 37 47 131 141 I-upper_bound
or 48 50 142 144 O
above 51 56 145 150 O
the 57 60 151 154 O
95th 61 65 155 159 B-lower_bound
percentile 66 76 160 170 I-lower_bound
) 76 77 170 171 O
for 78 81 172 175 O
height 82 88 176 182 O

Disseminated 0 12 183 195 B-chronic_disease
intravascular 13 26 196 209 I-chronic_disease
coagulation 27 38 210 221 I-chronic_disease
as 39 41 222 224 O
evidenced 42 51 225 234 O
by 52 54 235 237 O
prothrombin 55 66 238 249 B-clinical_variable
time 67 71 250 254 I-clinical_variable
or 72 74 255 257 O
partial 75 82 258 265 B-clinical_variable
thromboplastin 83 97 266 280 I-clinical_variable
time 98 102 281 285 I-clinical_variable
≥ 103 104 286 287 O
2X 105 107 288 290 B-lower_bound
the 108 111 291 294 I-lower_bound
ULN 112 115 295 298 I-lower_bound
or 116 118 299 301 O
platelets 119 128 302 311 B-clinical_variable
< 129 130 312 313 O
50 131 133 314 316 B-upper_bound
% 133 134 316 317 I-upper_bound
of 135 137 318 320 I-upper_bound
the 138 141 321 324 I-upper_bound
lower 142 147 325 330 I-upper_bound
limit 148 153 331 336 I-upper_bound
of 154 156 337 339 I-upper_bound
normal 157 163 340 346 I-upper_bound

Evidence 0 8 347 355 O
of 9 11 356 358 O
significant 12 23 359 370 O
hepatic 24 31 371 378 B-chronic_disease
disease 32 39 379 386 I-chronic_disease
or 40 42 387 389 O
dysfunction 43 54 390 401 O
, 54 55 401 402 O
including 56 65 403 412 O
known 66 71 413 418 O
acute 72 77 419 424 B-chronic_disease
viral 78 83 425 430 I-chronic_disease
hepatitis 84 93 431 440 I-chronic_disease
or 94 96 441 443 O
hepatic 97 104 444 451 B-chronic_disease
encephalopathy 105 119 452 466 I-chronic_disease

Female 0 6 467 473 B-gender
adolescent 7 17 474 484 I-gender
subjects 18 26 485 493 I-gender
who 27 30 494 497 O
are 31 34 498 501 B-pregnancy
pregnant 35 43 502 510 I-pregnancy
or 44 46 511 513 O
breastfeeding 47 60 514 527 O
or 61 63 528 530 O
have 64 68 531 535 O
a 69 70 536 537 O
positive 71 79 538 546 B-pregnancy
serum 80 85 547 552 I-pregnancy
β 86 87 553 554 I-pregnancy
- 87 88 554 555 I-pregnancy
hCG 88 91 555 558 I-pregnancy
pregnancy 92 101 559 568 I-pregnancy
test 102 106 569 573 O
at 107 109 574 576 O
screening 110 119 577 586 O
and 120 123 587 590 O
at 124 126 591 593 O
pre 127 130 594 597 O
- 130 131 597 598 O
dose 131 135 598 602 O
Day 136 139 603 606 O
1 140 141 607 608 O

Females 0 7 609 616 B-gender
who 8 11 617 620 O
are 12 15 621 624 O
of 16 18 625 627 O
childbearing 19 31 628 640 O
potential 32 41 641 650 O
and 42 45 651 654 O
unwilling 46 55 655 664 O
to 56 58 665 667 O
practice 59 67 668 676 O
abstinence 68 78 677 687 O
or 79 81 688 690 O
use 82 85 691 694 O
at 86 88 695 697 O
least 89 94 698 703 O
two 95 98 704 707 O
methods 99 106 708 715 O
of 107 109 716 718 O
contraception 110 123 719 732 O
( 124 125 733 734 O
oral 125 129 734 738 O
contraceptives 130 144 739 753 O
, 144 145 753 754 O
barrier 146 153 755 762 O
methods 154 161 763 770 O
, 161 162 770 771 O
approved 163 171 772 780 O
contraceptive 172 185 781 794 O
implant 186 193 795 802 O
) 193 194 802 803 O
during 195 201 804 810 O
the 202 205 811 814 O
entire 206 212 815 821 O
study 213 218 822 827 O
period 219 225 828 834 O

Hypothermia 0 11 835 846 B-chronic_disease
( 12 13 847 848 O
core 13 17 848 852 B-clinical_variable
temperature 18 29 853 864 I-clinical_variable
< 30 31 865 866 O
35.6 32 36 867 871 B-upper_bound
ºC 37 39 872 874 I-upper_bound
or 40 42 875 877 O
96.1 43 47 878 882 B-upper_bound
ºF 48 50 883 885 I-upper_bound
) 50 51 885 886 O

If 0 2 887 889 O
female 3 9 890 896 B-gender
and 10 13 897 900 O
has 14 17 901 904 O
reached 18 25 905 912 O
menarche 26 34 913 921 O
, 34 35 921 922 O
or 36 38 923 925 O
has 39 42 926 929 O
reached 43 50 930 937 O
Tanner 51 57 938 944 O
Stage 58 63 945 950 O
3 64 65 951 952 O
breast 66 72 953 959 O
development 73 84 960 971 O
( 85 86 972 973 O
even 86 90 973 977 O
if 91 93 978 980 O
not 94 97 981 984 O
having 98 104 985 991 O
reached 105 112 992 999 O
menarche 113 121 1000 1008 O
) 121 122 1008 1009 O
, 122 123 1009 1010 O
the 124 127 1011 1014 O
subject 128 135 1015 1022 O
is 136 138 1023 1025 O
practicing 139 149 1026 1036 B-contraception_consent
appropriate 150 161 1037 1048 I-contraception_consent
birth 162 167 1049 1054 I-contraception_consent
control 168 175 1055 1062 I-contraception_consent
or 176 178 1063 1065 O
is 179 181 1066 1068 O
sexually 182 190 1069 1077 O
abstinent 191 200 1078 1087 O

Known 0 5 1088 1093 O
significant 6 17 1094 1105 O
hypersensitivity 18 34 1106 1122 O
to 35 37 1123 1125 O
any 38 41 1126 1129 O
beta 42 46 1130 1134 B-allergy_name
- 46 47 1134 1135 I-allergy_name
lactam 47 53 1135 1141 I-allergy_name
antibiotic 54 64 1142 1152 I-allergy_name

Male 0 4 1153 1157 B-gender

Males 0 5 1158 1163 B-gender
who 6 9 1164 1167 O
are 10 13 1168 1171 O
unwilling 14 23 1172 1181 O
to 24 26 1182 1184 O
practice 27 35 1185 1193 O
abstinence 36 46 1194 1204 O
or 47 49 1205 1207 O
use 50 53 1208 1211 O
an 54 56 1212 1214 O
acceptable 57 67 1215 1225 O
method 68 74 1226 1232 O
of 75 77 1233 1235 O
broth 78 83 1236 1241 O
control 84 91 1242 1249 O
during 92 98 1250 1256 O
the 99 102 1257 1260 O
entire 103 109 1261 1267 O
study 110 115 1268 1273 O
period 116 122 1274 1280 O
( 123 124 1281 1282 O
i.e. 124 128 1282 1286 O
condom 129 135 1287 1293 O
with 136 140 1294 1298 O
spermicide 141 151 1299 1309 O
) 151 152 1309 1310 O

Neutropenia 0 11 1311 1322 O
with 12 16 1323 1327 O
absolute 17 25 1328 1336 B-clinical_variable
neutrophil 26 36 1337 1347 I-clinical_variable
count 37 42 1348 1353 I-clinical_variable
( 43 44 1354 1355 I-clinical_variable
ANC 44 47 1355 1358 I-clinical_variable
) 47 48 1358 1359 I-clinical_variable
< 49 50 1360 1361 O
500 51 54 1362 1365 B-upper_bound
cells 55 60 1366 1371 I-upper_bound
/ 60 61 1371 1372 I-upper_bound
mm3 61 64 1372 1375 I-upper_bound

Prior 0 5 1376 1381 O
exposure 6 14 1382 1390 O
to 15 17 1391 1393 O
vaborbactam 18 29 1394 1405 B-treatment
or 30 32 1406 1408 O
Vabomere 33 41 1409 1417 B-treatment

Receipt 0 7 1418 1425 O
of 8 10 1426 1428 O
any 11 14 1429 1432 O
investigational 15 30 1433 1448 O
medication 31 41 1449 1459 O
or 42 44 1460 1462 O
investigational 45 60 1463 1478 O
device 61 67 1479 1485 O
within 68 74 1486 1492 O
30 75 77 1493 1495 B-upper_bound
days 78 82 1496 1500 I-upper_bound
prior 83 88 1501 1506 I-upper_bound
to 89 91 1507 1509 O
enrollment 92 102 1510 1520 O

Signs 0 5 1521 1526 O
of 6 8 1527 1529 O
severe 9 15 1530 1536 B-chronic_disease
sepsis 16 22 1537 1543 I-chronic_disease

The 0 3 1544 1547 O
subject 4 11 1548 1555 O
will 12 16 1556 1560 O
be 17 19 1561 1563 O
observed 20 28 1564 1572 O
in 29 31 1573 1575 O
the 32 35 1576 1579 O
hospital 36 44 1580 1588 O
for 45 48 1589 1592 O
at 49 51 1593 1595 O
least 52 57 1596 1601 O
6 58 59 1602 1603 B-lower_bound
hours 60 65 1604 1609 I-lower_bound
after 66 71 1610 1615 O
the 72 75 1616 1619 O
study 76 81 1620 1625 O
drug 82 86 1626 1630 O
is 87 89 1631 1633 O
administered 90 102 1634 1646 O

Use 0 3 1647 1650 O
of 4 6 1651 1653 O
meropenem 7 16 1654 1663 B-treatment
within 17 23 1664 1670 O
48 24 26 1671 1673 B-upper_bound
hours 27 32 1674 1679 I-upper_bound
of 33 35 1680 1682 O
administration 36 50 1683 1697 O
of 51 53 1698 1700 O
study 54 59 1701 1706 O
drug 60 64 1707 1711 O
or 65 67 1712 1714 O
12 68 70 1715 1717 B-upper_bound
hours 71 76 1718 1723 I-upper_bound
after 77 82 1724 1729 O
study 83 88 1730 1735 O
drug 89 93 1736 1740 O
administration 94 108 1741 1755 O

age 0 3 1756 1759 B-age
and 4 7 1760 1763 O
weight 8 14 1764 1770 B-clinical_variable
except 15 21 1771 1777 O
for 22 25 1778 1781 O
children 26 34 1782 1790 O
< 35 36 1791 1792 O
2 37 38 1793 1794 B-upper_bound
years 39 44 1795 1800 I-upper_bound
of 45 47 1801 1803 O
age 48 51 1804 1807 O

from 0 4 1808 1812 O
birth 5 10 1813 1818 O
to 11 13 1819 1821 O
< 14 15 1822 1823 O
18 16 18 1824 1826 B-upper_bound
years 19 24 1827 1832 I-upper_bound
of 25 27 1833 1835 O
age 28 31 1836 1839 B-age

subjects 0 8 1840 1848 O
receiving 9 18 1849 1858 O
peri 19 23 1859 1863 O
- 23 24 1863 1864 O
operative 24 33 1864 1873 O
prophylactic 34 46 1874 1886 O
use 47 50 1887 1890 O
of 51 53 1891 1893 O
antibiotics 54 65 1894 1905 B-treatment

